Industry News
Aus cancer vaccine closer to human trials
Radvax, a cancer treatment vaccine, being developed by South Australian company Vaxine, is closer to human trials. [ + ]
Innate reveals "distressing" MS trial results
Innate Immunotherapeutics has reluctantly announced that its MS therapy MIS416 showed no meaningful or statistically significant results in a recent Phase 2B trial, with the company's shares dropping a whopping 92% as a result. [ + ]
Better managing antibiotic use in sepsis patients
UK researchers are taking part in a £1.5 million study aiming to antibiotic resistance in sepsis patients — the largest ever trial to look at biomarkers in the blood to see whether antibiotics should be continued or can be safely stopped. [ + ]
Prima says IMP321 trial progressing well
Prima BioMed has announced that the company's two active clinical trials in IMP321 are progressing well. [ + ]
Monash IVF and RHS begin non-invasive PGS trial
Australian listed companies Monash IVF and RHS (Reproductive Health Science) have partnered to develop an accurate way to test for chromosome number in embryos without biopsy. [ + ]
Miele expands medical tech business with Steelco stake purchase
Miele is set to acquire a controlling stake in the Steelco Group to further expand in the medical technology industry. [ + ]
Canadian CRO selected to reformulate cancer inhibitor
PharmAust has appointed contract research organisation BRI Pharmaceutical Research Inc to reformulate its lead drug candidate, Monepantel (MPL), for clinical trials. [ + ]
Cancer cells may streamline their genomes to replicate faster
A recent study, conducted in both human and mouse cells, has revealed that cancer cells might streamline their genomes in order to proliferate more easily. [ + ]
LBT Innovations completes CE mark certification for APAS
LBT Innovations and joint venture company Clever Culture Systems AG have completed a comprehensive essential requirements review of the extensive documentation and data packs related to the APAS technology and certify requirements are met for CE Marking. [ + ]
Genome regulation mystery solved
US researchers have addressed a longstanding question about how DNA functions are organised in space and time, including how genes are regulated to be silenced or expressed. [ + ]
New medical cannabis body launched
A new industry body, the Medical Cannabis Council, has been launched with an aim to develop best practice and standards for producing, supplying and distributing medical cannabis. [ + ]
Clinical trials provide $1.1bn to economy
Clinical trials accounted for roughly $1.1 billion in gross expenditure in 2015, and the annual expenditure could reach 2 billion in the next 10 years. [ + ]
When immune cells turn toxic
A subpopulation of immune cells that normally fend off pathogens can turn against the host during certain infections, an international research team has revealed. [ + ]
Lab Innovations 2017
Lab Innovations, the UK's dedicated show for laboratory technology, analytical and biotech equipment, returns for its sixth consecutive year from 1–2 November 2017 at the NEC, Birmingham. [ + ]
Genetic Signatures receives regulatory approval for Enteric products
Molecular diagnostics company Genetic Signatures has received Australian and European regulatory approval for its Enteric Viral Detection solution. This will allow the sale of the company's complete enteric suite within those regions, which represent 22% of the global molecular diagnostics market. [ + ]
